Cyclosporin nephrotoxicity in heart and lung transplant patients

QJM: An International Journal of Medicine

Volumn 89, Issue 10, 1996, Pages 751-763

  Griffiths, M H ^a,c   Crowe, A V ^a   Papadaki, L ^a   Banner, N R ^b   Yacoub, M H ^b   Thompson, F D ^a   Neild, G H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; PROTEIN;

ADULT; ARTERIOLE; ARTICLE; ATROPHY; BASEMENT MEMBRANE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; GLOMERULUS; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY ISCHEMIA; KIDNEY TUBULE; LUNG TRANSPLANTATION; MALE; NEPHROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRASTRUCTURE;

EID: 0029907375     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.10.751     Document Type: Article

References (26)

1. Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; ii 1323-7.
2. Kahan BD. Cyclosporine. N Engl J Med 1989; 321:1725.
3. Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990; 1:162.
4. Mihatsch MJ, Thief G, Ryfell B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20:759.
5. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporin-associated chronic nephropathy. N Engl J Med 1984; 311:699-705.
6. Myers BD, Sibley R, Newton L, Tomlanovich SJ, Boshkos C, Stinson E, Luertscher JA, Whitney DJ, Krasny D, Coplon NS, Perlroth MG. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33:590-600.
7. Myers BD, Newton L. Cyclosporin-induced chronic nephropathy: an obliterative microvascular injury. J Am Soc Nephrol 1991; 2(2 suppl 1):S45.
8. Bertani T, Ferrazzi P, Scheppati A, Ruggenenti P, Gamba A, Mecca G, Perico N, Imberti O, Remuzzi A, et al. Nature and extent of glomerular injury induced by cyclosporin in heart transplant patients. Kidney Int 1991; 40:243.
9. Parameshwar J, Schofield, Large, S. Long-term complications of cardiac transplantation. Br Heart J 1995; 74:341-2.
10. Zaltzman JS, Pei Y, Maurer J, Patterson A, Cattran DC. Cyclosporin nephrotoxicity in lung transplant recipients. Transplantation 1992; 54:875-8.
11. Cho WY, Terasaki PI, Graver B. Fifteen-year kidney graft survival. In: Terasaki PI, ed. Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory, 1989:325.
12. Zietse R, Balk AH, Dorpel MA, Meeter K, Bos E, Weimar W. Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant Recipients. Am J Nephrol 1994; 14:1-5.
13. Feutren G, Mihatsch MJ. Risk factors for cyclosporin-induced nephropathy in patients with autoimmune disease. N Engl J Med 1992; 326:1654-60.
14. Assan R, Timsit J, Feutren G, Bougneres P, Czernichow P, Hannedouche T, Boitard C, Noel LH, Mihatsh MJ, Bach JF. The kidney in cyclosporin A treated diabetic patients: a long-term clinicopathological study. Clin Nephrol 1994; 41:41-9.
15. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune diseases. Br J Rheumatal 1993; 32 Suppl 1:65-71.
16. Sund S, Forre O, Berg KJ, Kvein TK, Hovig T. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis. Clin Nephrol 1994; 41:33-40.
17. Fioretto P, Steffes MW, Mihatsch MJ, Strom EH, Sutherland DE, Mauer M. Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. Kidney Int 1995; 48:489-95.
18. Persson H, Norden G, Karlberg I, Friman S. Glomerular filtration rate after liver transplantation with a low-dose cyclosporin protocol. Transpl Int 1994; 7:172-6.
19. Mihatsch MJ, Thiel G, Ryffel B. Renal side-effects of cyclosporin A with special reference to autoimmune diseases. Br J Dermatol 1990; 122 Suppl 36:101-15.
20. Palestine AG, Austin HA, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporin for uveitis. N Engl J Med 1986; 314:1293-8.
21. Takeda A, Morozumi K, Uchida K, Yokoyama I, Tagagi H, Hoshida A, Fujinami T, Thiel G, Gudat F, Mihatsch MJ. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA? Transplant Proc 1993; 25:515-17.
22. Mihatsch MJ, Thiel G, Spichtin HP, et al. Morphological findings in kidney transplants after treatment with Cyclosporin. Trans Proc 1983; 15:2821-35.
23. Yamaguchi Y, Teraoka S, Yagisawa T, Takahashi K, Toma H, Ota K. Ultrastructural study of Cyclosporine-associated arteriolopathy in renal allografts. Trans Proc 1989; 21:1517-22.
24. Hammond EH, Yowell RL. Ultrastructural findings in cardiac transplant recipients. Ultrastruct Pathol 1994; 18:213-20.
25. Papadaki L, Griffiths M. Vascular rejection or cyclosporine toxicity? (Letter) Ultrastruct Pathol 1995; 19:145.
26. Burke M, Sloan R, Brier M, Ganzel B. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing. Transplantation 1995; 59:537-40.